search
Back to results

Goal Concordant Care Learning Laboratory

Primary Purpose

Cancer, Heart Failure, Copd

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Feedback
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cancer focused on measuring palliative care

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Duke Health patient Exclusion Criteria: None

Sites / Locations

  • Duke Health

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Intervention

Arm Description

Usual care

Feedback to provider regarding frequency and quality of communication

Outcomes

Primary Outcome Measures

Frequency of goals of care communication
Frequency of goals of care conversations in the last 6 months of life
Timing of goals of care communication
Proximity of goals of care communication to death

Secondary Outcome Measures

Full Information

First Posted
May 14, 2023
Last Updated
September 21, 2023
Sponsor
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT05879211
Brief Title
Goal Concordant Care Learning Laboratory
Official Title
Palliative Care Learning Laboratory
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
July 12, 2023 (Actual)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
July 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.
Detailed Description
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness. The lab will test a variety of interventions, including triggered conversations and feedback to healthcare providers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer, Heart Failure, Copd, Dementia
Keywords
palliative care

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Several interventions will be tested, at the patient and provider levels
Masking
None (Open Label)
Allocation
Randomized
Enrollment
5000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual care
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Feedback to provider regarding frequency and quality of communication
Intervention Type
Behavioral
Intervention Name(s)
Feedback
Intervention Description
Providers will receive detailed feedback about the timing, quality, and frequency of their goals of care communication with patients
Primary Outcome Measure Information:
Title
Frequency of goals of care communication
Description
Frequency of goals of care conversations in the last 6 months of life
Time Frame
2 years
Title
Timing of goals of care communication
Description
Proximity of goals of care communication to death
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Duke Health patient Exclusion Criteria: None
Facility Information:
Facility Name
Duke Health
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Goal Concordant Care Learning Laboratory

We'll reach out to this number within 24 hrs